New Research

Rebates are Unrelated to Drugmakers’ Pricing Strategies

View Study

PCMA Ad: “Just Cut the Price”

America’s PBMs agree with the Administration and Patients. The most direct way to reduce costs and improve access to prescription drugs is for drugmakers to cut their prices.

View the Ad

Opioid Crisis

PCMA Highlights PBM Solutions to Address the Opioid Crisis

Visit the Site

Drug Benefit Solutions

PBMs reduce costs & generate savings

Visit the Site

New Research

Eliminating Drugmaker Rebates Leads to Higher Medicare Part D Premiums

View Study

PCMA Press Releases

PCMA EVENTS

PCMA hosts three annual events: the sPCMA Business Forum, the PBM Policy Forum, and the PCMA Annual Meeting

PCMA’s conference brand is known for bringing together thought leaders and pharmacy benefit decision makers from PBMs, specialty pharmacies, and pharma and biotech manufacturers.

Learn More

PCMA POLICY & ISSUES

ABOUT OUR INDUSTRY

PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others. PBMs are projected to save employers, unions, government programs, and consumers $654 billion— up to 30 percent—on drug benefit costs over the next decade.

Stay Connected with PCMA!